In comparing the effects of sulfur mustard (SM)-induced cell death in adult cultured normal human epidermal keratinocytes (NHEK) and peripheral blood lymphocytes (PBL), we observed an SM concentration-and time-dependent loss of NHEK and PBL viability as measured by propidium iodide exclusion. By this parameter alone, PBL appeared more susceptible to SM-induced cytotoxi-city than NHEK, as previously reported. However, therewas a concentration-and time-dependent loss of NHEK yield that was not observed in PBL. Keratinocyte yield was approximately 46% and 8% of control cells at 12 and 24 hours, respectively, following exposure to 0.3 mM SM. The decrease in NHEK yield was associated with an increase in trypan blue-stained fragments observed on slides. Fragments were not observed on slides of SM-exposed PBL cultures. These results suggest that SM causes fragmentation of cultured NHEK and subsequently results in a lower cell yield. The fragmented dead NHEK are not included in the total cell count when percent viability is determined by propidium iodide exclusion. Therefore, cytotoxicity of SM in NHEK is greater than that reflected by dye exclusion alone. Actual viable cell count, which considers both propidium iodide exclusion and cellyield, indicates NHEK are more susceptible than PBL to SM-induced cytotoxicity, contrary to previously published reports. Cell yield must be taken into account when using in vitro models to study not only viability, but also any quantitative biochemical changes induced by SM.
Anslow, W. P., and Houck, C. R.. 1946. Systemic pharmacology and pathology of sulfur and nitrogen mustards. In Chemical warfare agents and related chemical problems (DTIC AD245 270), ed. National Defense Research Committee, 440–479. Washington, DC: U.S. Office of Scientific Research and Development.
2.
Clayson, E. T., Kelly, S. A., and Meier, H. L.1993. Effects of specific inhibitors of cellular functions on sulfur mustard-induced cell death. Cell Biol. Toxicol.9:165–175.
3.
Clonetics Corporation. 1993. Clonetics'normalhuman epidermalkeratinocytes. In Clonetics corporation 1993 normal human cell systems catalog, 6–7. San Diego, California.
4.
Cohen, B.. 1946. Kinetic reactions of sulfur and nitrogen mustards. In Chemical warfare agents and related chemical problems (DTIC AD245 270), ed. National Defense Research Committee, 415–430. Washington, DC: U.S. Office of Scientific Research and Development.
5.
Cowan, F. M., Broomfield, C. A., and Smith, W. J.1992. Inhibition of sulfur mustard-increased protease activity by niacinamide, N-acetyl-L-cysteine or dexamethasone. Cell Biol. Toxicol.8:129–138.
6.
Cowan, F. M., Broomfield, C. A., and Smith, W. J.1996. Enhanced proteolytic activity and Fc receptor expression in human epithelial cells following exposure to sulfur mustard. In Proceedings of the 1996 medical defense bioscience review (ADI A321841). Aberdeen Proving Ground, Maryland: U.S. Army Medical Research Institute of Chemical Defense, 819–827.
7.
Cowan, F. M., Yourick, J. J., Hurst, C. G., Broomfield, C. A., and Smith, W. J.1993. Sulfur mustard-increased proteolysis following in vitro and in vivo exposures. Cell Biol. Toxicol.9:269–277.
8.
Cullumbine, H.. 1947. Medical aspects of mustard gas poisoning. Nature159:151–153.
9.
Ginzler, A. M., and Davis, M. I. J.1943. The pathology of mustard burns of human skin. Edgewood Arsenal, Maryland: U.S. Army Medical Research Laboratory, Report No. 3.
10.
Kurt, E. M., Schafer, R. J., Broomfield, C. A., Kahler, D. W., and Arroyo, C. M.1997. Immunologic cytokine expression in human keratinocytes after exposure to sulfur mustard. J. Am. Coll. Toxicol.15(Suppl. 2):S32–S35.
11.
Loken, M. R.1990. Immunofluorescence techniques. In Flow cytometry and sorting, 2nd ed., ed. M. R. Melamed, T. Lindmo, and M. L. Mendelsohn, 341–353. New York: Wiley-Liss.
12.
Martens, M. E.1997. In vitro studies of glucose metabolism in human epidermal keratinocytes exposed to sulfur mustard. J. Am. Coll. Toxicol.15(Suppl. 2):S19–S31.
13.
Medema, J.. 1986. Mustard gas: The science of H. Nuclear, Biological, and Chemical Defense and Technology International1:66–71.
14.
Meier, H. L., Clayson, E. T., Kelly, S. A., and Corun, C. M.1996. Effect of sulfur mustard (HD) on ATP levels of human lymphocytes cultured in vitro. In VitroToxicol.9:135–139.
15.
Meier, H. L., Gross, C. L., and Papirmeister, B.. 1987. 2,2′-dichlorodiethyl sulfide (sulfur mustard) decreases NAD+ levels in human leukocytes. Toxicol. Lett.39:109–122.
16.
Meier, H. L., and Johnson, J. B.1992. The determination and prevention of cytotoxic effects induced in human lymphocytes by the alkylating agent 2,2′-dichlorodiethyl sulfide (sulfur mustard, HD). Toxicol. Appl. Pharmacol.113:234–239.
17.
Mol, M. A. E., and van de Ruit, A. M. B. C.. 1992. Concentration-and time-related effects of sulphur mustard on human epidermal keratinocyte function. Toxicol. In Vitro6:245–251.
18.
Mol, M. A. E., van de Ruit, A. M. B. C., and Kluivers, A. W.1989. NAD+ levels and glucose uptake of cultured human epidermal cells exposed to sulfur mustard. Toxicol. Appl. Pharmacol.98:159–165.
19.
Papirmeister, B., Feister, A. J., Robinson, S. I., and Ford, R. D.1991a. Chemistry of sulfur mustard. In Medical defense against mustard gas, ed. (Editors), 91–122. Boston: CRC Press.
20.
Papirmeister, B., Feister, A. J., Robinson, S. I., and Ford, R. D.1991b. Experimental models of sulfur mustard injury. In Medical defense against mustard gas, ed. (Editors), 43–78. Boston: CRC Press.
21.
Papirmeister, B., Feister, A. J., Robinson, S. I., and Ford, R. D.1991c. Experimental models of sulfur mustard injury. In Medical defense against mustard gas, ed. (Editors), 299–347. Boston: CRC Press.
22.
Papirmeister, B., Gross, C. L., Petrali, J. P., and Meier, H. L.1984. Pathology produced by sulfur mustard in human skin grafts on athymic nude mice. II. Ultrastructural changes. J. Toxicol. Cutan. Ocu. Toxicol.3:393–408.
23.
Renshaw, B.. 1946. Mechanisms in production of cutaneous injuries by sulfur and nitrogen mustards. In Chemical warfare agents and related chemical problems (DTIC AD245 270), ed. National Defense Research Committee, 470–518. Washington, DC: U.S. Office of Scientific Research and Development.
24.
Smith, W. J., Blank, J. A., Starner, R. A., Menton, R. G., and Harris, J.. 1996. Effect of sulfur mustard exposure on human epidermal kerat inocyte viability and protein content. In Proceedings of the 1996 medical defense bioscience review (ADI A321841), 1105–1113. Aberdeen Proving Ground, Maryland: U.S. Army Medical Research Institute of Chemical Defense.
25.
Smith, W. J., Gross, C. L., Chan, P., and Meier, H. L.1990. The use of human epidermal keratinocytes in culture as a model for studying the biochemical mechanisms of sulfur mustard toxicity. Cell Biol. Toxicol.6:285–291.
26.
Smith, W. J., Sanders, K. M., Caulfield, J. E., and Gross, C. L.1992. Sulfur mustard-induced biochemical alterations in proliferating human cells in culture. J. Toxicol. Cutan. Ocu. Toxicol.11:293–304.
27.
Smith, W. J., Sanders, K. M., Gales, Y. A., and Gross, C. L.1991. Flow cytometric analysis of toxicity by vesicating agents in human cells in vitro. J. Toxicol. Cutan. Ocu. Toxicol.10:33–42.
28.
Smith, W. J., Sanders, K. M., Ruddle, S. E., and Gross, C. L.1993. Cytometric analysis of DNA changes induced by sulfur mustard. J. Toxicol. Cutan. Ocu. Toxicol.12:337–347.
29.
Warthin, S. W., and Weller, C. V.1919. The medical aspects of mustard gas poisoning.St. Louis: CV Mosby Co.
30.
Willems, J. L.1989. Clinical management of mustard gas casualties. Ann. Med. Milit. (Belg)3 (Suppl):1–61.
